These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 12401952)
21. Generation of ferric iron links oxidative stress to α-synuclein oligomer formation. Levin J; Högen T; Hillmer AS; Bader B; Schmidt F; Kamp F; Kretzschmar HA; Bötzel K; Giese A J Parkinsons Dis; 2011; 1(2):205-16. PubMed ID: 23934922 [TBL] [Abstract][Full Text] [Related]
22. Translocation of iron from lysosomes into mitochondria is a key event during oxidative stress-induced hepatocellular injury. Uchiyama A; Kim JS; Kon K; Jaeschke H; Ikejima K; Watanabe S; Lemasters JJ Hepatology; 2008 Nov; 48(5):1644-54. PubMed ID: 18846543 [TBL] [Abstract][Full Text] [Related]
23. alpha-Synuclein selectively increases manganese-induced viability loss in SK-N-MC neuroblastoma cells expressing the human dopamine transporter. Pifl C; Khorchide M; Kattinger A; Reither H; Hardy J; Hornykiewicz O Neurosci Lett; 2004 Jan; 354(1):34-7. PubMed ID: 14698476 [TBL] [Abstract][Full Text] [Related]
24. Adamantyl- and other polycyclic cage-based conjugates of desferrioxamine B (DFOB) for treating iron-mediated toxicity in cell models of Parkinson's disease. Telfer TJ; Liddell JR; Duncan C; White AR; Codd R Bioorg Med Chem Lett; 2017 Apr; 27(8):1698-1704. PubMed ID: 28285915 [TBL] [Abstract][Full Text] [Related]
25. alpha-synuclein promotes mitochondrial deficit and oxidative stress. Hsu LJ; Sagara Y; Arroyo A; Rockenstein E; Sisk A; Mallory M; Wong J; Takenouchi T; Hashimoto M; Masliah E Am J Pathol; 2000 Aug; 157(2):401-10. PubMed ID: 10934145 [TBL] [Abstract][Full Text] [Related]
26. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell. Richardson D; Ponka P; Baker E Cancer Res; 1994 Feb; 54(3):685-9. PubMed ID: 8306330 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells. Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835 [TBL] [Abstract][Full Text] [Related]
33. Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells. Hasegawa T; Matsuzaki M; Takeda A; Kikuchi A; Akita H; Perry G; Smith MA; Itoyama Y Brain Res; 2004 Jul; 1013(1):51-9. PubMed ID: 15196967 [TBL] [Abstract][Full Text] [Related]
34. Relocalized redox-active lysosomal iron is an important mediator of oxidative-stress-induced DNA damage. Kurz T; Leake A; Von Zglinicki T; Brunk UT Biochem J; 2004 Mar; 378(Pt 3):1039-45. PubMed ID: 14670081 [TBL] [Abstract][Full Text] [Related]
35. Deferoxamine attenuates lipopolysaccharide-induced inflammatory responses and protects against endotoxic shock in mice. Wang S; Liu C; Pan S; Miao Q; Xue J; Xun J; Zhang Y; Gao Y; Duan X; Fan Y Biochem Biophys Res Commun; 2015 Sep; 465(2):305-11. PubMed ID: 26277391 [TBL] [Abstract][Full Text] [Related]
36. Influence of calcium and iron on cell death and mitochondrial function in oxidatively stressed astrocytes. Robb SJ; Robb-Gaspers LD; Scaduto RC; Thomas AP; Connor JR J Neurosci Res; 1999 Mar; 55(6):674-86. PubMed ID: 10220109 [TBL] [Abstract][Full Text] [Related]
37. The iron chelator deferoxamine prevents cisplatin-induced lipid peroxidation in rat kidney cortical slices. Kameyama Y; Gemba M Jpn J Pharmacol; 1991 Oct; 57(2):259-62. PubMed ID: 1812305 [TBL] [Abstract][Full Text] [Related]
38. Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress. Sappey C; Boelaert JR; Legrand-Poels S; Forceille C; Favier A; Piette J AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1049-61. PubMed ID: 8554902 [TBL] [Abstract][Full Text] [Related]
39. Iron chelation study in a normal human hepatocyte cell line suggests that tumor necrosis factor receptor-associated protein 1 (TRAP1) regulates production of reactive oxygen species. Im CN; Lee JS; Zheng Y; Seo JS J Cell Biochem; 2007 Feb; 100(2):474-86. PubMed ID: 16927372 [TBL] [Abstract][Full Text] [Related]
40. Cell cycle-dependent inhibition of the proliferation of human neural tumor cell lines by iron chelators. Renton FJ; Jeitner TM Biochem Pharmacol; 1996 Jun; 51(11):1553-61. PubMed ID: 8630097 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]